immunotherapeutic vaccine (Aterovax/INSERM)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameimmunotherapeutic vaccine (Aterovax/INSERM)
Drug Alias NameT-lymphocyte stimulator (Aterovax/INSERM)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionT lymphocytes stimulantsImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitut National De La Sante Et De La Recherche Medicale
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitut National De La Sante Et De La Recherche MedicaleAterovax SA
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A